The GORE ® EXCLUDER ® Iliac Branch Endoprosthesis (IBE) is the only FDA approved, off-the-shelf iliac branch solution and is designed to preserve blood flow to external and internal iliac arteries.

The GORE ® EXCLUDER ® Iliac Branch Endoprosthesis (IBE) is intended to be used with the GORE ® EXCLUDER ® AAA Endoprosthesis or the GORE ® EXCLUDER ® Conformable AAA Endoprosthesis to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries in patients with a common ...

The GORE ® EXCLUDER ® Iliac Branch Endoprosthesis is the first complete system* fully designed for the iliac branch, built from the same GORE ® EXCLUDER ® Device platform you’ve trusted for years. U.S. IDE Clinical Trial has 5-year follow up data. * Gore designed iliac branch and internal components.

The GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) is the first and only commercially available iliac branch device in the United States. The early and midterm outcomes have shown excellent technical success and patency rates, without increase in mortality or stent graft–related complications. 7

2021年8月25日 · 近日W. L. Gore & Associates（戈尔）在2021年血管外科学会年会上公布了使用GORE® EXCLUDER® 髂动脉瘤血管内修复术（IBE）的美国前瞻性多中心研究（N = 63）的5年结果。研究结果证实了IBE治疗主动脉和髂动脉瘤的安全性、有效性和耐久性。

The GORE® EXCLUDER® lliac Branch Endoprosthesis (IBE) provides endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. The GORE® EXCLUDER® lliac Branch Endoprosthesis is comprised of two components, the Iliac Branch Component (IBC) (Figure 1) and the Internal Iliac Component (IIC) (Figure 2). The Iliac Branch ...

The GORE® EXCLUDER® Iliac Branch Device Clinical Study, a prospective, multicenter, non-randomized, single-arm study designed to assess the safety and effectiveness of the IBE in treating common iliac artery aneurysms or aortoiliac aneurysms, completed enrollment in …

会议诚邀血管外科的国内外专家，以专题演讲、病例分享以及数据解读等多种形式，共同探讨胸、腹主新器具——gore® ibe髂动脉分支支架和gore® tag® 可主动调控胸主动脉覆膜支架系统在血管疾病治疗领域的应用及激荡出的新思考、新理念和新技术。

The Gore Iliac Branch Endoprosthesis (IBE; W. L. Gore & Associates, Flagstaff, Ariz) has recently been approved by the Food and Drug Administration for treatment of common iliac artery (CIA) aneurysms. Despite early excellent results in clinical trial, none of 63 patients were treated for bilateral iliac aneurysms.

FLAGSTAFF, Ariz., Aug. 19, 2021 /PRNewswire/ -- W. L. Gore & Associates (Gore), today announced that five-year results of the U.S. prospective, multicenter study (N = 63) of endovascular repair...